We Think Nuvation Bio (NYSE:NUVB) Can Easily Afford To Drive Business Growth

We Think Nuvation Bio (NYSE:NUVB) Can Easily Afford To Drive Business Growth

Investing in unprofitable businesses like biotech and mining exploration can be lucrative, but many companies end up bankrupt due to cash burn. Nuvation Bio (NYSE:NUVB) has a cash runway of 9.3 years, reducing cash burn by 29% last year.

Read More

Did you find this insightful?